IRIS Accounts Production v26.3.0.614 10392438 Board of Directors 1.1.25 31.12.25 31.12.25 7/10/26 false true false false true false Auditors Opinion Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh103924382024-12-31103924382025-12-31103924382025-01-012025-12-31103924382023-12-31103924382024-01-012024-12-31103924382024-12-3110392438ns15:EnglandWales2025-01-012025-12-3110392438ns14:PoundSterling2025-01-012025-12-3110392438ns10:Director12025-01-012025-12-3110392438ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3110392438ns10:SmallEntities2025-01-012025-12-3110392438ns10:Audited2025-01-012025-12-3110392438ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3110392438ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3110392438ns10:FullAccounts2025-01-012025-12-3110392438ns10:OrdinaryShareClass12025-01-012025-12-3110392438ns10:Director22025-01-012025-12-3110392438ns10:Director32025-01-012025-12-3110392438ns10:RegisteredOffice2025-01-012025-12-3110392438ns5:CurrentFinancialInstruments2025-12-3110392438ns5:CurrentFinancialInstruments2024-12-3110392438ns5:ShareCapital2025-12-3110392438ns5:ShareCapital2024-12-3110392438ns5:RevaluationReserve2025-12-3110392438ns5:RevaluationReserve2024-12-3110392438ns5:RetainedEarningsAccumulatedLosses2025-12-3110392438ns5:RetainedEarningsAccumulatedLosses2024-12-3110392438ns5:PlantMachinery2025-01-012025-12-3110392438ns5:PlantMachinery2024-12-3110392438ns5:PlantMachinery2025-12-3110392438ns5:PlantMachinery2024-12-3110392438ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3110392438ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3110392438ns5:CurrentFinancialInstruments2025-01-012025-12-3110392438ns5:WithinOneYear2025-12-3110392438ns5:WithinOneYear2024-12-3110392438ns5:BetweenOneFiveYears2025-12-3110392438ns5:BetweenOneFiveYears2024-12-3110392438ns5:AllPeriods2025-12-3110392438ns5:AllPeriods2024-12-3110392438ns5:AcceleratedTaxDepreciationDeferredTax2025-12-3110392438ns5:AcceleratedTaxDepreciationDeferredTax2024-12-3110392438ns5:TaxLossesCarry-forwardsDeferredTax2025-12-3110392438ns5:TaxLossesCarry-forwardsDeferredTax2024-12-3110392438ns5:DeferredTaxation2024-12-3110392438ns5:DeferredTaxation2025-01-012025-12-3110392438ns5:DeferredTaxation2025-12-3110392438ns10:OrdinaryShareClass12025-12-311039243812025-01-012025-12-31
REGISTERED NUMBER: 10392438 (England and Wales)


















AUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

FOR

THE PROTEIN PARTNERS LTD

THE PROTEIN PARTNERS LTD (REGISTERED NUMBER: 10392438)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3 to 7


THE PROTEIN PARTNERS LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2025







DIRECTORS: J N Langslow
D Murphy
A D Davies





REGISTERED OFFICE: Dean Court
85 Adlington Road
Wilmslow
SK9 2BT





REGISTERED NUMBER: 10392438 (England and Wales)





INDEPENDENT AUDITORS: Allens Accountants Limited
Statutory Auditor and
Chartered Accountants
123 Wellington Road South
Stockport
Cheshire
SK1 3TH

THE PROTEIN PARTNERS LTD (REGISTERED NUMBER: 10392438)

BALANCE SHEET
31 DECEMBER 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 555,667 620,514

CURRENT ASSETS
Stocks 1,387,466 2,596,312
Debtors 5 788,281 724,980
Cash at bank and in hand 106,442 213,247
2,282,189 3,534,539
CREDITORS
Amounts falling due within one year 6 3,042,158 4,227,187
NET CURRENT LIABILITIES (759,969 ) (692,648 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(204,302

)

(72,134

)

PROVISIONS FOR LIABILITIES 8 132,911 142,602
NET LIABILITIES (337,213 ) (214,736 )

CAPITAL AND RESERVES
Called up share capital 9 250,000 250,000
Revaluation reserve 10 95,537 144,328
Retained earnings (682,750 ) (609,064 )
SHAREHOLDERS' FUNDS (337,213 ) (214,736 )

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 7 October 2026 and were signed on its behalf by:





J N Langslow - Director


THE PROTEIN PARTNERS LTD (REGISTERED NUMBER: 10392438)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1. STATUTORY INFORMATION

The Protein Partners Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern
At 31 December 2025 the company had net liabilities of £337,213. The company is dependent on the continued financial support of its parent undertaking, County Milk Products Limited, which has confirmed that it will continue to provide such support, and will not seek repayment of amounts owed to it where this would leave the company unable to meet its other liabilities, for a period of at least twelve months from the date of approval of these financial statements. On this basis the directors consider it appropriate to prepare the financial statements on the going concern basis.

Related party exemption
The company is a wholly owned subsidiary of County Milk Products Limited. The company has taken advantage of the exemption in Section 33 of FRS 102 not to disclose transactions with other wholly owned members of the group.

Turnover
Turnover represents the amounts receivable for goods sold, excluding value added tax and net of discounts and rebates.

Turnover is recognised when the significant risks and rewards of ownership have passed to the customer, which is determined in accordance with the agreed terms of sale. For UK customers this is generally on delivery, and for overseas customers at the point specified in the contract.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 5% to 25% on cost

Stocks
Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

Financial instruments
The company has only basic financial instruments, comprising trade and other debtors, cash, trade and other creditors and amounts owed to group undertakings. These are initially recognised at transaction price and subsequently measured at amortised cost, less any impairment in the case of financial assets. Balances receivable or payable within one year, and amounts owed to group undertakings which are repayable on demand, are measured at the undiscounted amount expected to be received or paid.


THE PROTEIN PARTNERS LTD (REGISTERED NUMBER: 10392438)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Operating leases
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the lease term.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 43 (2024 - 42 ) .

THE PROTEIN PARTNERS LTD (REGISTERED NUMBER: 10392438)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2025 1,364,725
Additions 68,289
Disposals (2,200 )
At 31 December 2025 1,430,814
DEPRECIATION
At 1 January 2025 744,211
Charge for year 132,879
Eliminated on disposal (1,943 )
At 31 December 2025 875,147
NET BOOK VALUE
At 31 December 2025 555,667
At 31 December 2024 620,514

Certain tangible fixed assets were revalued on a fair value basis in 2018 by Tallon and Associates, independent valuers, and have since been depreciated over their remaining useful lives. Tangible fixed assets at 31 December 2025 include assets at a valuation of £583,093 (2024: £583,093), with all other assets stated at cost. The net book value of the revalued assets at 31 December 2025 was £124,049 (2024: £176,665), all of which represents the revaluation surplus.

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 685,600 569,217
Other debtors 102,681 155,763
788,281 724,980

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 551,279 888,393
Amounts owed to group undertakings 2,362,380 3,181,644
Taxation and social security 89,260 25,898
Other creditors 39,239 131,252
3,042,158 4,227,187

Amounts owed to group undertakings are unsecured, interest free and repayable on demand.

THE PROTEIN PARTNERS LTD (REGISTERED NUMBER: 10392438)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

7. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2025 2024
£    £   
Within one year 84,000 111,000
Between one and five years 218,750 302,750
302,750 413,750

8. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred tax
Accelerated capital allowances 104,399 106,692
Unutilised tax losses - (5,751 )
Revalued assets 28,512 41,661
132,911 142,602

Deferred
tax
£   
Balance at 1 January 2025 142,602
Credit to Income Statement during year (9,691 )
Balance at 31 December 2025 132,911

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
250,000 Ordinary £1 250,000 250,000

10. RESERVES

Called up share capital represents the nominal value of shares issued.

The revaluation reserve represents the surplus arising on the revaluation of certain tangible fixed assets, net of deferred tax. Each year an amount equal to the excess depreciation on the revalued assets, net of deferred tax, is transferred to retained earnings. Deferred tax has been provided on the revaluation surplus.

Retained earnings represent cumulative profits and losses, net of any distributions to shareholders and transfers from the revaluation reserve.

11. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Dean McMullan (Senior Statutory Auditor)
for and on behalf of Allens Accountants Limited

THE PROTEIN PARTNERS LTD (REGISTERED NUMBER: 10392438)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

12. CAPITAL COMMITMENTS

There were no capital commitments contracted but not provided for at 31 December 2025 (2024: £nil).

13. POST BALANCE SHEET EVENTS

There have been no significant events affecting the company since the year end.

14. PARENT UNDERTAKING

The company's immediate and ultimate parent undertaking is County Milk Products Limited, a company registered in England and Wales (company number 02873177), whose registered office is Dean Court, 85 Adlington Road, Wilmslow, Cheshire, SK9 2BT. County Milk Products Limited prepares group financial statements which include the company, copies of which can be obtained from its registered office.

The ultimate controlling party is Mr J N Langslow, by virtue of his majority of the voting rights in County Milk Products Limited.